ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 37650231.
- Also identified by DOI 10.1093/infdis/jiad246 and PMC identifier 10469341.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Clinical Trials Registration ClinicalTrials.gov Identifier: NCT04518410.
Medical subject headings
- COVID-19
- COVID-19 Drug Treatment
- Antiviral Agents